Herbalife Ltd. (NYSE:HLF - Get Free Report) Director Juan Miguel Mendoza purchased 2,500 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were bought at an average cost of $8.00 per share, for a total transaction of $20,000.00. Following the completion of the transaction, the director now directly owns 135,000 shares in the company, valued at $1,080,000. This trade represents a 1.89 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link.
Juan Miguel Mendoza also recently made the following trade(s):
- On Thursday, February 27th, Juan Miguel Mendoza purchased 5,000 shares of Herbalife stock. The shares were bought at an average cost of $8.25 per share, for a total transaction of $41,250.00.
Herbalife Stock Up 0.4 %
Shares of HLF stock traded up $0.04 during mid-day trading on Friday, hitting $8.86. 3,024,497 shares of the stock were exchanged, compared to its average volume of 2,857,486. The firm has a fifty day moving average of $6.65 and a 200 day moving average of $7.21. Herbalife Ltd. has a 52-week low of $5.04 and a 52-week high of $12.79. The company has a market cap of $896.10 million, a PE ratio of 3.56, a price-to-earnings-growth ratio of 0.29 and a beta of 1.03.
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.28. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. Equities analysts predict that Herbalife Ltd. will post 1.57 EPS for the current year.
Analyst Ratings Changes
Separately, DA Davidson reissued a "neutral" rating and set a $7.50 target price on shares of Herbalife in a research note on Thursday, February 20th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $9.90.
View Our Latest Stock Analysis on HLF
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of HLF. Arrowstreet Capital Limited Partnership lifted its stake in Herbalife by 777.0% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,987,490 shares of the company's stock valued at $19,986,000 after buying an additional 2,646,848 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in Herbalife by 67.0% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 2,570,226 shares of the company's stock valued at $17,195,000 after buying an additional 1,031,078 shares in the last quarter. Long Focus Capital Management LLC lifted its stake in Herbalife by 27.3% in the 4th quarter. Long Focus Capital Management LLC now owns 4,758,127 shares of the company's stock valued at $31,832,000 after buying an additional 1,020,127 shares in the last quarter. Vanguard Group Inc. lifted its stake in Herbalife by 7.5% in the 4th quarter. Vanguard Group Inc. now owns 11,271,417 shares of the company's stock valued at $75,406,000 after buying an additional 785,574 shares in the last quarter. Finally, Marshall Wace LLP lifted its stake in Herbalife by 83.8% in the 4th quarter. Marshall Wace LLP now owns 1,444,343 shares of the company's stock valued at $9,663,000 after buying an additional 658,536 shares in the last quarter.
About Herbalife
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Stories

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.